Yunhua Xu

发表

FBXL 5-mediated degradation of single-stranded DNA-binding protein hSSB 1 controls DNA damage response

Shun Lu, X. Niu, B. Liu, 2014 .

FBXL5-mediated degradation of single-stranded DNA-binding protein hSSB1 controls DNA damage response

Shun Lu, B. Liu, X. Niu, 2014, Nucleic acids research.

Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial

Zhihao Lu, Yanqiao Zhang, Q. Fan, 2022, Innovation (Cambridge (Mass.)).

Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma.

Shun Lu, Zhiwei Chen, Yunhua Xu, 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Non-significant efficacy of icotinib plus pleurodesis in epidermal growth factor receptor positive mutant lung cancer patients after malignant pleural effusion drainage compared to icotinib alone

Zhen Zhou, Yunhua Xu, L. Gu, 2020, Journal of thoracic disease.

An open, observational, three-arm clinical study of 2–3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis

Shun Lu, X. Niu, Yuchen Han, 2022, Frontiers in Immunology.

Integrative genomic analysis of drug resistance in MET exon 14 skipping lung cancer using patient-derived xenograft models

Shun Lu, Liu Liu, Yuchen Han, 2022, Frontiers in Oncology.

Efficacy and safety of a new disposable percutaneous positioning device invented to facilitate the precision of percutaneous core needle lung biopsies: a prospective, open and randomized controlled study

Jian-ding Ye, Yunhua Xu, Jun Fu, 2021, Journal of thoracic disease.

X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population

Tao Wu, Yunhua Xu, Xiao-lei Ye, 2013, Tumor Biology.

A Randomized Controlled Study of rhTPO and rhIL-11 for the Prophylactic Treatment of Chemotherapy-Induced Thrombocytopenia in Non-Small Cell Lung Cancer

Qiong Zhao, Li Liu, Yunhua Xu, 2018, Journal of Cancer.

Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma

Jiayi Wang, Xiao Zhang, F. Meng, 2022, Cancer communications.

Regulation of β-catenin-mediated esophageal cancer growth and invasion by miR-214.

Shun Lu, Yunhua Xu, S. Lu, 2015, American journal of translational research.

Recombinant human thrombopoietin combined with interleukin-2 improves the effects of chemosensitivity and thrombocytopenia on a basic gemcitabine and carboplatin combination therapy for non-small cell lung cancer in a nude mouse model.

Zhen Zhou, Yunhua Xu, Yan Pan, 2019, Journal of thoracic disease.

Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay

Lin Wang, J. Lou, Yunhua Xu, 2019, Journal of Cancer.

Xenograft tumors derived from malignant pleural effusion of the patients with non-small-cell lung cancer as models to explore drug resistance

Danyi Wen, Shun Lu, Jie Zhang, 2018, Cancer communications.

17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway

Q. Luo, Shun Lu, X. Niu, 2015, Journal of cellular and molecular medicine.

Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma

Jian Zhang, Xuelin Zhang, M. Kong, 2015, Journal of surgical oncology.

Transforming growth factor-β1-induced epithelial to mesenchymal transition increases mitochondrial content in the A549 non-small cell lung cancer cell line.

Yunhua Xu, S. Lu, 2015, Molecular medicine reports.

AZD0530 sensitizes drug‐resistant ALK‐positive lung cancer cells by inhibiting SRC signaling

Shun Lu, Yi Zhao, Yi Yang, 2017, FEBS open bio.

Metformin Inhibits Esophagus Cancer Proliferation through Upregulation of USP7

Shun Lu, Yunhua Xu, S. Lu, 2013, Cellular Physiology and Biochemistry.

Genetic polymorphisms in oxidative stress-related genes are associated with clinical outcome in patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitors.

Jian Zhang, Chunyan He, Xuelin Zhang, 2014, American journal of cancer research.

No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis

Yunhua Xu, L. Gu, Bai-jun Cheng, 2013, Tumor Biology.

Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors.

Zhen Zhou, Shun Lu, X. Niu, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Ultrafast Synthesizing Bismuth Mesoporous Nanolitchi Radiosensitizer Loading High Dose DOX for CT Guided Enhanced Chemoradiotherapy.

Jie Liu, Y. Miao, Jianping Zhang, 2019, ACS applied materials & interfaces.

The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2

Shun Lu, X. Niu, Zhiwei Chen, 2014, FEBS letters.

Mesoporous Bi-contained Radiosensitizer Loading with DOX to Repolarize Tumor Associated Macrophages and Elicit Immunogenic Tumor Cell Death to Inhibit Tumor Progression.

Xiaodong Wu, Jie Liu, YingJian Zhang, 2020, ACS applied materials & interfaces.

Role of WNT 1-inducible-signaling pathway protein 1 in etoposide resistance in lung adenocarcinoma A 549 cells

Shun Lu, Yunhua Xu, 2015 .

Mini‐patient‐derived xenograft assay based on microfluidic technology promises to be an effective tool for screening individualized chemotherapy regimens for advanced non‐small cell lung cancer

Danyi Wen, Shun Lu, Zhiwei Chen, 2021, Cell biology international.

Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions: A case report

Yuchen Han, H. Jian, Yunhua Xu, 2022, Medicine.

Genetic polymorphisms in oxidative stress-related genes are associated with clinical outcome in patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitors.

Jian Zhang, Chunyan He, Xuelin Zhang, 2014, American journal of cancer research.

Integrated In Silico-In Vitro Discovery of Lung Cancer-related Tumor Pyruvate Kinase M2 (PKM2) Inhibitors.

Xiangyun Ye, Yunhua Xu, Shun Lu, 2016, Medicinal chemistry (Shariqah (United Arab Emirates)).

Assessment of interfering factors and clinical risk associated with discontinuation of pemetrexed maintenance therapy in advanced non-squamous non-small cell lung cancer.

Shun Lu, X. Niu, H. Jian, 2017, Lung cancer.